Evidence & regulatory context
- Mechanism
- Composite polyelectrolyte membrane dressing; no ChEMBL drug entity. Component searches for dihydroquercetin (taxifolin) returned no ChEMBL record. No ClinicalTrials.gov record for this formulation.
- Target
- Not recorded
- Injury models
- Wound
- Reported indication
- Not recorded
- First approval
- Not recorded
- Development stage
- Not recorded
- ChEMBL record
- Not recorded
- ChEMBL max phase
- Not recorded
- Synonyms
- Not recorded
- Note
- Not recorded
Clinical trials 0
0 linked trials carry an injury-indication flag. These flags support record-level exploration and sit alongside the stringent aggregate counts described in Methods.
No linked human trial in this dataset.
Preclinical evidence 1
1 studies reported at therapy level; 1 evidence entries itemised.
RatWoundWistar albinoFemaleTopical dressing
Model: Full-thickness excisional skin wound
Chitosan/hyaluronan/phosphatidylcholine dihydroquercetin films significantly reduced wound area and produced more prominent re-epithelialisation than cotton gauze or chitosan/hyaluronan dressings.
Extraction: extract · Supplied extraction confidence: 0.55. Machine-extracted fields require source verification.
